Condition: Presbyopia · Sponsor: VIS, Inc.
The goal of this clinical trial is to evaluate the safety and efficacy of using the VIS Opti-K System to enable monovision by providing temporary improvement in near vision through the treatment of the non-dominant eye of low myopic, emmetropic and low hyperopic presbyope subjects. The main questions it aims to answer are determining uncorrected near visual acuity at 40cm in the treated eye and subjective improvement as measured by the patient satisfaction questionnaire.
This description comes directly from the study's public registry record.
Kristy Wort · (214) 855-1222 · kwort@totalcro.com
George Aubrey · (724) 822-1838 · gaubrey@aol.com
Always discuss trial participation with your own doctor first.
| Cohen Laser & Vision Center | Boca Raton, Florida, United States | Recruiting |
| Claris Vision Eye Health | South Dartmouth, Massachusetts, United States | Recruiting |
| The Cornea & Laser Eye Institute | Teaneck, New Jersey, United States | Recruiting |
| OCLI Vision - Oceanside | Oceanside, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06487897